About
The Journal "Obstetrics and Gynecology"Journal HistoryAims and ScopePolicies on Conflict of Interest, Human and Animal Rights, and Informed ConsentEditorial ProcessData sharing statementAdvertising PolicyThe Process for Handling Cases Requiring Corrections, Retractions, and Editorial Expressions of ConcernEditorial BoardEditorial CounsilInformation for ProfessionalsNewsContacts
ArchiveEthical StandardsSubscription
For authors
InstructionsInformed consent policyContract offerEASE GuidelinesICJME CriteriaWAME Recommendations on ChatGPT and Chatbots in Relation to Scholarly Publications
Reviewing
Procedure for reviewingReviewers 2023-2024
ISSN 0300-9092 (Print)
ISSN 2412-5679 (Online)
About
The Journal "Obstetrics and Gynecology"Journal HistoryAims and ScopePolicies on Conflict of Interest, Human and Animal Rights, and Informed ConsentEditorial ProcessData sharing statementAdvertising PolicyThe Process for Handling Cases Requiring Corrections, Retractions, and Editorial Expressions of ConcernEditorial BoardEditorial CounsilInformation for ProfessionalsNewsContacts
ArchiveEthical StandardsSubscription
For authors
InstructionsInformed consent policyContract offerEASE GuidelinesICJME CriteriaWAME Recommendations on ChatGPT and Chatbots in Relation to Scholarly Publications
Reviewing
Procedure for reviewingReviewers 2023-2024
Logout
Obstetrics and Gynegology2025№4
Sex hormone binding globulin and...

Sex hormone binding globulin and its role in the development of endometriosis

DOI
https://dx.doi.org/10.18565/aig.2024.323

Ponomareva T.A., Altukhova O.B., Ponomarenko I.V., Churnosov M.I.

1) Belgorod State National Research University, Belgorod, Russia; 2) St. Joasaph Belgorod Regional Clinical Hospital, Belgorod, Russia

Endometriosis is one of the most common gynecological diseases of the female reproductive system, and sex hormones play an important role in its pathogenesis. Sex hormone binding globulin (SHBG), a plasma glycoprotein, specifically binds androgens and estrogens and regulates the levels of biologically active (free) steroid hormones in plasma. The SHBG level in the body is influenced by age, gender, and body mass index. Genetic factors are important in determining the SHBG levels. The SHBG expression is negatively affected by monosaccharides, insulin and androgens, while thyroid and estrogenic hormones as well as phytoestrogens, on the contrary, increase its production. The high levels of estrogen and low levels of testosterone are associated with an increased risk of endometriosis. Since SHBG is important in the regulation of testosterone and estrogen levels, there is obviously an association between the SHBG levels and the likelihood of endometriosis.
Conclusion: The literature review suggests that SHBG plays a significant role in regulating the level of biologically active sex hormones in the body, and this role is frequently underestimated by medical professionals. The SHBG levels and its genetic determinants may be promising biological markers that can predict the risk of endometriosis. Further research in this area is required to provide evidence for the use of SHBG in clinical practice.

Authors’ contributions: Ponomareva T.A. – literature search and analysis, evidence summary, writing the text of the manuscript; Ponomarenko I.V. – editing the text of the manuscript; Altukhova O.B. – developing the concept and design of the article; Churnosov M.I. – reviewing, final editing.
Conflicts of interest: Authors declare lack of the possible conflicts of interests.
Funding: The study was conducted without sponsorship.
For citation: Ponomareva T.A., Altukhova O.B., Ponomarenko I.V., Churnosov M.I. 
Sex hormone binding globulin and its role in the development of endometriosis.
Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2025; (4): 5-11 (in Russian)
https://dx.doi.org/10.18565/aig.2024.323

Keywords

sex hormone binding globulin
endometriosis
estrogens
testosterone
Full text (in Russian)

References

  1. Адамян Л.В., Андреева Е.Н. Эндометриоз и его глобальное влияние на организм женщины. Проблемы репродукции. 2022; 28(1): 54-64. [Adamyan L.V., Andreeva E.N. Endometriosis and its global impact on a woman’s body. Russian Journal of Human Reproduction. 2022; 28(1): 54-64. (in Russian)]. https://dx.doi.org/10.17116/repro20222801154.
  2. Smolarz B., Szyllo K., Romanowicz H. Endometriosis: epidemiology, classification, pathogenesis, treatment and genetics (review of literature). Int. J. Mol. Sci. 2021; 22(19): 10554. https://dx.doi.org/10.3390/ijms221910554.
  3. Головченко И.О. Генетические детерминанты уровня половых гормонов у больных эндометриозом. Научные результаты биомедицинских исследований. 2023; 9(1): 5-21. [Golovchenko I.O. Genetic determinants of sex hormone levels in endometriosis patients. Research Results in Biomedicine. 2023; 9(1): 5-21. (in Russian)]. https://dx.doi.org//10.18413/2658-6533-2023-9-1-0-1.
  4. Пономаренко И.В., Полоников А.В., Чурносов М.И. Молекулярные механизмы и факторы риска развития эндометриоза. Акушерство и гинекология. 2019; 3: 26-31. [Ponomarenko I.V., Polonikov A.V., Churnosov M.I. Molecular mechanisms of and risk factors for endometriosis. Obstetrics and Gynecology. 2019; (3): 26-31. (in Russian)]. https://dx.doi.org/10.18565/aig.2019.3.26-31.
  5. Pillerova M., Borbelyova V., Hodosy J., Riljak V., Renczes E., Frick K.M. et al. On the role of sex steroids in biological functions by classical and non-classical pathways. An update. Front. Neuroendocrinol. 2021; 62: 100926. https://dx.doi.org/10.1016/j.yfrne.2021.100926.
  6. Chanphai P., Vesper A.R., Bariyanga J., Bérubé G., Tajmir-Riahi H.A. Review on the delivery of steroids by carrier proteins. J. Photochem. Photobiol. B. 2016; 161: 184-91. https://dx.doi.org/10.1016/j.jphotobiol.2016.05.015.
  7. Ma H., Chen Y. Examining the causal relationship between sex hormone-binding globulin (SHBG) and infertility: A Mendelian randomization study. PLoS One. 2024; 19(6): e0304216. https://dx.doi.org/10.1371/journal.pone.0304216.
  8. Simons P.I.H.G., Valkenburg O., Stehouwer C.D.A., Brouwers M.C.G.J. Sex hormone-binding globulin: biomarker and hepatokine? Trends Endocrinol. Metab. 2021; 32(8): 544-53. https://dx.doi.org/10.1016/j.tem.2021.05.002.
  9. Qu X., Donnelly R. Sex Hormone-Binding Globulin (SHBG) as an early biomarker and therapeutic target in polycystic ovary syndrome. Int. J. Mol. Sci. 2020; 21(21): 8191. https://dx.doi.org/10.3390/ijms21218191.
  10. Хаханина Т.И., Осипенкова Н.Г. Органическая химия: учебное пособие для среднего профессионального образования. М.: Издательство «Юрайт»; 2019. 396 с. [Khakhanina T.I., Osipenkova N.G. Organic Chemistry. A textbook for secondary vocational education. Moscow: Yurayt Publishing House; 2019. 396p. (in Russian)].
  11. Grishkovskaya I., Avvakumov G.V., Sklenar G., Dales D., Hammond G.L., Muller Y.A. Crystal structure of human sex hormone-binding globulin: steroid transport by a laminin G-like domain. EMBO J. 2000; 19(4): 504-12. https://dx.doi.org/10.1093/emboj/19.4.504.
  12. Hammond G.L. Plasma steroid-binding proteins: primary gatekeepers of steroid hormone action. J. Endocrinol. 2016; 230(1): R13-25. https://dx.doi.org/10.1530/JOE-16-0070.
  13. Avvakumov G.V., Cherkasov A., Muller Y.A., Hammond G.L. Structural analyses of sex hormone-binding globulin reveal novel ligands and function. Mol. Cell. Endocrinol. 2010; 316(1): 13-23. https://dx.doi.org/10.1016/j.mce.2009.09.005.
  14. Zhu J.L., Chen Z., Feng W.J.., Long SL., Mo Z.C. Sex hormone-binding globulin and polycystic ovary syndrome. Clin. Chim. Acta. 2019; 499: 142-8. https://dx.doi.org/10.1016/j.cca.2019.09.010.
  15. Shi Y., Zhou D., Wang B., Zhou D., Shi B. Roles and mechanisms of action of HNF 4α in the hepatic differentiation of WB F344 cells. Int. J. Mol. Med. 2019; 43(2): 1021-32. https://dx.doi.org/10.3892/ijmm.2018.4010.
  16. Aribas E., Roeters van Lennep J.E., De Rijke Y.B., Laven J.S.E., Ikram M.A., Peeters R. et al. Sex steroids and sex steroid-binding globulin levels amongst middle-aged and elderly men and women from general population. Eur. J. Clin. Invest. 2022; 52(12): 13866. https://dx.doi.org/10.1111/eci.13866.
  17. Ramachandran S., Hackett G.I., Strange R.C. Sex hormone binding globulin: a review of its interactions with testosterone and age, and its impact on mortality in men with type 2 diabetes. Sex. Med. Rev. 2019; 7(4): 669-78. https://dx.doi.org/10.1016/j.sxmr.2019.06.006.
  18. Grasa M.D.M., Gulfo J., Camps N., Alcalá R., Monserrat L., Moreno-Navarrete J.M. et al. Modulation of SHBG binding to testosterone and estradiol by sex and morbid obesity. Eur. J. Endocrinol. 2017; 176(4): 393-404. https://dx.doi.org/10.1530/EJE-16-0834.
  19. Wittert G., Grossmann M. Obesity, type 2 diabetes, and testosterone in ageing men. Rev. Endocr. Metab. Disord. 2022; 23(6): 1233-42. https://dx.doi.org/10.1007/s11154-022-09746-5.
  20. Coviello A.D., Zhuang W.V., Lunetta K.L., Bhasin S., Ulloor J., Zhang A. et al. Circulating testosterone and SHBG concentrations are heritable in women: the Framingham Heart Study. J. Clin. Endocrinol. Metab. 2011; 96(9): 1491-5. https://dx.doi.org/10.1210/jc.2011-0050.
  21. Jaquish C.E., Blangero J., Haffner S.M., Stern M.P., MacCluer J.W. Quantitative genetics of serum sex hormone-binding globulin levels in participants in the San Antonio Family Heart Study. Metabolism. 1997; 46(9): 988-91. https://dx.doi.org//10.1016/s0026-0495(97)90266-3.
  22. Ring H.Z., Lessov C.N., Reed T., Marcus R., Holloway L., Swan G.E. et al. Heritability of plasma sex hormones and hormone binding globulin in adult male twins. J. Clin. Endocrinol. Metab. 2005; 90(6): 3653-8. https://dx.doi.org/10.1210/jc.2004-1025.
  23. Ruth K.S., Day F.R., Tyrrell J., Thompson D.J., Wood A.R., Mahajan A. et al. Using human genetics to understand the disease impacts of testosterone in men and women. Nat. Med. 2020; 26(2): 252-8. https://dx.doi.org/10.1038/s41591-020-0751-5.
  24. Coviello A.D., Haring R., Wellons M., Vaidy, D., Lehtimäki T., Keildson S. et al. A genome-wide association meta-analysis of circulating sex hormone-binding globulin reveals multiple loci implicated in sex steroid hormone regulation. PLoS Genet. 2012; 8(7): 1002805. https://dx.doi.org//10.1371/journal.pgen.1002805.
  25. Backman J.D., Li A.H., Marcketta A., Sun D., Mbatchou J., Kessler M.D. et al. Exome sequencing and analysis of 454,787 UK Biobank participants. Nature. 2021; 599(7886): 628-34. https://dx.doi.org/10.1038/s41586-021-04103-z.
  26. Пономарева Т.А., Алтухова О.Б., Пономаренко И.В., Чурносов М.И. Роль генетических факторов в формировании эндометриоидных поражений. Акушерство, гинекология и репродукция. 2023; 17(4): 443-54. [Ponomareva T.A., Altukhova O.B., Ponomarenko I.V., Churnosov M.I. The role of genetic factors in developing endometrioid lesions. Obstetrics, Gynecology and Reproduction. 2023; 17(4): 443-54. (in Russian)]. https://dx.doi.org/10.17749/2313-7347/ob.gyn.rep.2023.434.
  27. Пасенов К.Н. Особенности ассоциаций SHBG-связанных генов с раком молочной железы у женщин в зависимости от наличия наследственной отягощенности и мутаций в генах BRCA1/CHEK2. Научные результаты биомедицинских исследований. 2024; 10(1): 69-88. [Pasenov K.N. Features of associations of SHBG-related genes with breast cancer in women, depending on the presence of hereditary burden and mutations in the BRCA1/CHEK2 genes. Research Results in Biomedicine. 2024; 10(1): 69-88. (in Russian)]. https://dx.doi.org/10.18413/2658-6533-2024-10-1-0-4.
  28. Leinonen J.T., Mars N., Lehtonen L.E., Ahola-Olli A., Ruotsalainen S., Lehtimäki T. et al. Genetic analyses implicate complex links between adult testosterone levels and health and disease. Commun. Med. (Lond.). 2023; 3(1): 4. https://dx.doi.org/10.1038/s43856-022-00226-0.
  29. Saunders P.T.K. Insights from genomic studies on the role of sex steroids in the aetiology of endometriosis. Reprod. Fertil. 2022; 3(2): R51-R65. https://dx.doi.org/10.1530/RAF-21-0078.
  30. Андреев А.Е., Клейменова Т.С., Дробинцева А.О., Полякова В.О., Кветной И.М. Сигнальные молекулы, вовлеченные в образование новых нервных окончаний при эндометриозе (обзор). Научные результаты биомедицинских исследований. 2019; 5(1): 94-107. [Andreev A.E., Kleimenova T.S., Drobintseva A.O., Polyakova V.O., Kvetnoi I.M. Signal molecules involved in the formation of new nerve endings in endometriosis (review). Research Results in Biomedicine. 2019; 5(1): 94-107 (in Russian)]. https://dx.doi.org/10.18413/2313-8955-2019-5-1-0-7.
  31. Tűű L., Nas K., Török M., Várbíró S. SHBG levels do not correlate with insulin levels in PCOS with appropriate fasting insulin sensitivity. J. Clin. Med. 2024; 13(3): 838. https://dx.doi.org/10.3390/jcm13030838.
  32. McGrath I.M., International Endometriosis Genetics Consortium, Montgomery G.W., Mortlock S. Polygenic risk score phenome-wide association study reveals an association between endometriosis and testosterone. BMC Med. 2023; 21(1): 482. https://dx.doi.org/10.1186/s12916-023-03184-z.
  33. Ponomarenko M.S., Reshetnikov E.A., Churnosova M.M., Reshetnikova Yu.N., Churnosov V.I., Ponomarenko I.V. Comorbidity and syntropy of benign proliferative diseases of the female reproductive system: non-genetic, genetic, and epigenetic factors (review). Research Results in Biomedicine. 2023; 9(4): 544-56. https://dx.doi.org/10.18413/2658- 6533-2023-9-4-0-9.
  34. Dinsdale N., Nepomnaschy P., Crespi B. The evolutionary biology of endometriosis. Evol. Med. Public Health. 2021; 9(1): 174-91. https://dx.doi.org/10.1093/emph/eoab008.
  35. Zhao B., Wang Z., Liu D., Zhang S. Genetically predicted serum testosterone and risk of gynecological disorders: a Mendelian randomization study. Front. Endocrinol. 2023; 14: 1161356. https://dx.doi.org/10.3389/fendo.2023.1161356.
  36. Ford C. An overview of the female reproductive system. Br. J. Nurs. 2023; 32(9): 420-6. https://dx.doi.org/10.12968/bjon.2023.32.9.420.
  37. Sheng J.A., Bales N.J., Myers S.A., Bautista A.I., Roueinfar M., Hale T.M. et al. The hypothalamic-pituitary-adrenal axis: development, programming actions of hormones, and maternal-fetal interactions. Front. Behav. Neurosci. 2021; 14: 601939. https://dx.doi.org/10.3389/fnbeh.2020.601939.
  38. Dinsdale N.L., Crespi B.J. Endometriosis and polycystic ovary syndrome are diametric disorders. Evol. Appl. 2021; 14(7): 1693-715. https://dx.doi.org/10.1111/eva.13244.
  39. Schwartz C.L., Christiansen S., Vinggaard A.M., Axelstad M., Hass U., Svingen T. Anogenital distance as a toxicological or clinical marker for fetal androgen action and risk for reproductive disorders. Arch. Toxicol. 2019; 93(2): 253-72. https://dx.doi.org/10.1007/s00204-018-2350-5.
  40. Stilley J.A., Birt J.A., Sharpe-Timms K.L. Cellular and molecular basis for endometriosis-associated infertility. Cell. Tissue Res. 2012; 349(3): 849-62. https://dx.doi.org/10.1007/s00441-011-1309-0.
  41. Romanski P.A., Brady P.C., Farland L.V., Thomas A.M., Hornstein M.D. The effect of endometriosis on the antimüllerian hormone level in the infertile population. J. Assist. Reprod. Genet. 2019; 36(6): 1179-84. https://dx.doi.org/10.1007/s10815-019-01450-9.
  42. Dong Z., An J., Xie X., Wang Z., Sun P. Preoperative serum anti-Müllerian hormone level is a potential predictor of ovarian endometrioma severity and postoperative fertility. Eur. J. Obstet. Gynecol. Reprod. Biol. 2019; 240: 113-20. https://dx.doi.org/10.1016/j.ejogrb.2019.06.024.
  43. Deswal R., Yadav A., Dang A.S. Sex hormone binding globulin - an important biomarker for predicting PCOS risk: A systematic review and meta-analysis. Syst. Biol. Reprod. Med. 2018; 64(1): 12-24. https://dx.doi.org/10.1080/19396368.2017.1410591.
  44. Howdeshell K.L., Hotchkiss A.K., Gray L.E. Jr. Cumulative effects of antiandrogenic chemical mixtures and their relevance to human health risk assessment. Int. J. Hyg. Environ. Health. 2017; 220(2 Pt A): 179-88. https://dx.doi.org/10.1016/j.ijheh.2016.11.007.
  45. Whitehouse A.J., Gilani S.Z., Shafait F., Mian A., Tan D.W., Maybery M.T. et al. Prenatal testosterone exposure is related to sexually dimorphic facial morphology in adulthood. Proc. Biol. Sci. 2015; 282(1816): 20151351. https://dx.doi.org/10.1098/rspb.2015.1351.
  46. Bulun S.E. Endometriosis caused by retrograde menstruation: now demonstrated by DNA evidence. Fertil. Steril. 2022; 118(3): 535-6. https://dx.doi.org/10.1016/j.fertnstert.2022.07.012.
  47. Narinx N., David K., Walravens J., Vermeersch P., Claessens F., Fiers T. et al. Role of sex hormone-binding globulin in the free hormone hypothesis and the relevance of free testosterone in androgen physiology. Cell. Mol. Life Sci. 2022; 79(11): 543. https://dx.doi.org/10.1007/s00018-022-04562-1.
  48. Пономаренко И.В., Полоников А.В., Верзилина И.Н., Чурносов М.И. Молекулярно-генетические детерминанты развития эндометриоза. Вопросы гинекологии, акушерства и перинатологии. 2019; 18(1): 82-6. [Ponomarenko I.V., Polonikov A.V., Verzilina I.N., Churnosov M.I. Molecular-genetic determinants of the development of endometriosis. Gynecology, Obstetrics and Perinatology. 2019; 18(1): 82-6. (in Russian)]. https://dx.doi.org/10.20953/1726-1678-2019-1-82-86.
  49. Golovchenko I., Aizikovich B., Golovchenko O., Reshetnikov E., Churnosova M., Aristova I. et al. Sex hormone candidate gene polymorphisms are associated with endometriosis. Int. J. Mol. Sci. 2022; 23(22): 13691. https://dx.doi.org/10.3390/ijms232213691.
  50. Marquardt R.M., Kim T.H., Shin J.H., Jeong J.W. Progesterone and estrogen signaling in the endometrium: What goes wrong in endometriosis?. Int. J. Mol. Sci. 2019; 20(15): 3822. https://dx.doi.org/10.3390/ijms20153822.
  51. Kobayashi H., Kimura M., Maruyama S., Nagayasu M., Imanaka S. Revisiting estrogen-dependent signaling pathways in endometriosis: Potential targets for non-hormonal therapeutics. Eur. J. Obstet. Gynecol. Reprod. Biol. 2021; 258: 103-10. https://dx.doi.org/10.1016/j.ejogrb.2020.12.044.
  52. Bulun S.E., Monsavais D., Pavone M.E., Dyson M., Xue Q., Attar E. et al. Role of estrogen receptor-β in endometriosis. Semin. Reprod. Med. 2012; 30(1): 39-45. https://dx.doi.org/10.1055/s-0031-1299596.
  53. Misao R., Hori M., Ichigo S., Fujimoto J., Tamaya T. Levels of sex hormone-binding globulin (SHBG) and corticosteroid-binding globulin (CBG) messenger ribonucleic acid (mRNAs) in ovarian endometriosis. Reprod. Nutr. Dev. 1995; 35(2): 155-65. https://dx.doi.org/10.1051/rnd:19950204.
  54. Shafrir A.L., Mu F., Eliassen A.H., Thombre Kulkarni M., Terry K.L., Hankinson S.E. et al. Endogenous steroid hormone concentrations and risk of endometriosis in Nurses' Health Study II. Am. J. Epidemiol. 2023; 192(4): 573-86. https://dx.doi.org/10.1093/aje/kwac219.
  55. Радзинский В.Е., Алтухова О.Б. Молекулярно-генетические детерминанты бесплодия при генитальном эндометриозе. Научные результаты биомедицинских исследований. 2018; 4(3): 28-37. [Radzinsky V.E., Altuchova O.B. Molecular-genetic determinants of infertility in genital endometryosis. Research Results in Biomedicine. 2018; 4(3): 28-37 (in Russian)]. https://dx.doi.org/10.18413/2313-8955-2018-4-3-0-3.

Received 07.12.2025

Accepted 21.03.2025

About the Authors

Tatiana A. Ponomareva, PhD student, Department of Medical and Biological Disciplines, Belgorod State National Research University, 85 Pobedy str., 308007, Belgorod, Russia; Obstetrician-Gynecologist, St. Joasaph Belgorod Regional Clinical Hospital, 8/9 Nekrasov str., 308015, Belgorod, Russia, rybaarbusova@icloud.com,
https://orcid.org/0009-0007-8533-9319
Oxana B. Altukhova, Dr. Med. Sci., Associate Professor, Head of the Department of Obstetrics and Gynecology, Belgorod State National Research University, 85 Pobedy str., 308007, Belgorod, Russia; Head of Gynecological Department, St. Joasaph Belgorod Regional Clinical Hospital, 8/9 Nekrasov str., 308015, Belgorod, Russia,
altuhova_o@bsuedu.ru, https://orcid.org/0000-0003-4674-8797
Irina V. Ponomarenko, Dr. Med. Sci., Associate Professor at the Department of Medical and Biological Disciplines, Belgorod State National Research University, 85 Pobedy str., 308007, Belgorod, Russia, ponomarenko_i@bsuedu.ru, https://orcid.org/0000-0002-5652-0166
Mikhail I. Churnosov, Dr. Med. Sci., Professor, Head of the Department of Medical and Biological Disciplines, Belgorod State National Research University, 85 Pobedy str.,
308007, Belgorod, Russia, churnosov@bsuedu.ru, https://orcid.org/ 0000-0003-1254-6134
Corresponding author: Tatyana A. Ponomareva, rybaarbusova@icloud.com

Similar Articles

№11 / 2024
Menzhinskaya I.V., Pavlovich S.V., Melkumyan A.G., Chuprynin V.D.
A profile of autoantibodies to steroid hormones and steroidogenic enzymes in women with endometriosis
№11 / 2024
Managadze I.D., Nesterova A.A., Levakova O.S., Levakov S.A.
Psychoemotional aspects and somatic status of women with endometriosis: is there a link?
№11 / 2024
Khashukoeva A.Z., Agaeva M.I., Agaeva Z.A., Savchenko T.N., Lobacheva Yu.I., Gubzhokova L.B., Lukyanova E.A.
The use of Buserelin-depo in the treatment of endometriosis
№11 / 2024
Kolpakova T.G., Kochergina M.S., Averkova V.G., Yureneva S.V., Samushiya M.A.
Mental health and sexual function in women with premature ovarian insufficiency
№4 / 2025
Bezhenar V.F., Linde V.A., Kuzmina N.S., Krylova N.Yu., Lyogonkaya A.Yu.
Deep infiltrative endometriosis and fertility
By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.